Venmax Drugs and Pharmaceuticals Ltd Closes Trading Window after Q4 Results for FY2026

Venmax Drugs and Pharmaceuticals Ltd has announced the closure of the trading window for all insiders, including designated persons and their immediate relatives, effective from April 1, 2026. This closure is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for Prevention of Insider Trading. The closure comes 48 hours after the declaration of the audited financial results for the quarter and year ended March 31, 2026. The date of the board meeting for the consideration of these results will be intimated in due course.